The global cannabis market is on a steep growth trajectory, valued at USD 72.83 billion in 2025 and projected to surge to USD 125.76 billion by 2030, reflecting an impressive CAGR of 11.5%. This momentum is fuelled by expanding legalization across regions, rising therapeutic applications, and broader consumer acceptance of both medical and recreational cannabis products.
As the industry matures, advancements in edibles, vapes, and infused products have prompted stronger quality-control measures, while increasing health awareness and clinical research continue to shape regulatory frameworks. More stringent scrutiny of product potency and content has also heightened consumer awareness around safe and responsible use.
Nutraceutical & Wellness: The Fastest-Growing Application Segment
One of the most dynamic segments in the cannabis industry is nutraceutical and wellness. These products focus on supporting daily health, nutrition, and well-being without inducing strong psychoactive effects. Often formulated with CBD and low levels of THC, they offer therapeutic benefits for:
- Stress and anxiety
- Sleep disorders
- Mild inflammation
- Chronic pain
- Skin health
The market spans a wide range of formats, including CBD oils, capsules, gummies, functional edibles, topicals, beverages, and skincare products. This shift toward plant-based, natural wellness solutions reflects a broader consumer movement seeking balanced lifestyles and preventive health support — without the high associated with recreational cannabis.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301
CBD-Dominant Products: A Strong Market Contender
CBD continues to hold a significant position, emerging as the second-largest segment by compound type. Its non-psychoactive nature and expanding therapeutic reputation have driven adoption across wellness, sports recovery, skincare, and nutraceuticals. CBD is widely recognized for its ability to support:
- Sleep regulation
- Pain management
- Stress reduction
- Anti-inflammatory needs
Innovations are also shaping the CBD landscape. In May 2025, Charlotte’s Web launched Brightside, a micro-dose THC gummy line combined with CBD, CBG, and CBC to target specific wellness needs. Meanwhile, technological improvements—such as supercritical CO₂ extraction—are enhancing product purity and efficiency, further propelling market growth.
North America Leads the Global Cannabis Market
North America is anticipated to retain the largest market share through 2030, supported by:
- Widespread legalization for medical & recreational use
- Strong clinical evidence validating cannabis benefits
- High consumer acceptance
- Continuous innovation in edibles, topicals, beverages, and wellness formats
Regulatory oversight in the region is extensive, involving bodies such as the FDA, DEA, Health Canada, and various state-level boards. Rising demand for natural alternatives for managing chronic pain, anxiety, and sleep disorders further accelerates market expansion.
Leading Cannabis Companies:
The competitive landscape includes major global and regional players driving innovations, clinical research, and product diversification. Notable companies include:
- Canopy Growth Corporation (Canada)
- Curaleaf (US)
- Cresco Labs (US)
- Green Thumb Industries (US)
- Tilray Brands (US)
- Aurora Cannabis Inc. (Canada)
- Trulieve (US)
- MedMen (US)
- Blüm Holdings Inc. (US)
- Organigram Global (Canada)
- TerrAscend (US)
- Village Farms International Inc. (US)
- Verano (US)
- The Cronos Group (Canada)
- Medical Marijuana, Inc. (US)
